🔗 Share this article Social Media Influencers Fueling Parallel Trade for Unapproved Slimming Medication An underground market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations. Investigational Treatment Gaining Popularity Via Social Media Retatrutide, which is still in clinical trials, is being advertised by online personalities for its supposed weight-reducing properties. Viewers are urged to contact these accounts privately for supplier links, while also receiving promotional offers. Active Commerce on Messaging Platforms Separately, a flourishing market exists on Telegram, where communities with numerous of members share comparison images, administration instructions and assertions of next-day British shipping. Vendors promote the drug there before redirecting customers to other platforms for purchases. Learning About Retatrutide Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic. Medical Experts Voice Worries However, physicians and pharmacists have warned that the distribution of what remains an unapproved drug in the UK is a cause for concern and could result in individuals injecting substances of uncertain source. Some experts said the popularity for the experimental drug could be linked to the rising cost of licensed weight loss treatments such as Mounjaro. Legal Position and Enforcement Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be promoted or supplied for human use under the Human Medicines Regulations 2012. Several content creators attempt to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still breach medicines, advertising, and consumer laws, risking penalties, legal action or imprisonment. Platform Response and Material Removal Based on TikTok, the service has removed violative content and prohibited associated keywords and search suggestions. The company stated it was dedicated to keeping the platform secure and investing in enhancing enforcement strategies. Online Marketplace Activities Investigations also found communities with up to 9,000 members selling the experimental drug using Telegram's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly brings up channels with thousands of users, filled with images of weight loss, positive reviews and step-by-step guides for preparing or injecting at home. Within moments of joining one community, a seller posted WhatsApp details, where the majority of purchases take place. The seller provided an instruction manual and promised delivery within 48 hours. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about body mass, health issues or previous experience. Product Information and Pricing Inside these communities, posts display black plastic parcels with Royal Mail stickers, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.” Buyers can select between powder vials, prepared at residence with purified liquid, or ready-to-use injectors typically priced at 160 pounds for 20mg. When questioned how much time a pen should be used, sellers give contradictory answers ranging from a few weeks to “depends on your body”. Service Moderation and Safety Measures A spokesperson for the messaging service stated it actively moderated dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”. Healthcare Professional Cautions “People are administering materials they cannot confirm. Although the research behind this drug is sound, these online products may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service. A medical professional of an online medical service connected the surge in interest to recent price rises for authorized slimming drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But fake injections are highly risky. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she said. Her team has already seen individuals injured by self-injection from unverified suppliers. “We recognize the frustration, but purchasing from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These materials could be impure or improperly measured.” Producer Position A representative from Eli Lilly stated retatrutide was in third stage clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this point no one can market [it] for human use,” they explained, noting that any product “falsely representing itself as a company investigational product not yet approved … may expose patients to possibly significant health risks”.